According to the latest estimates from the Indian Council of Medical Research’s (ICMR) National Cancer Registry Programme, brain tumours represent the majority of central nervous system (CNS) cancers recorded across various population-based registries in India. The data highlights the rising prevalence of these complex cancers, underscoring the urgent need for heightened awareness and timely diagnosis.
Brain tumours are abnormal growths of cells within the brain or its immediate surroundings. As per ICMR’s cancer registries, CNS cancers—primarily brain tumours—constitute a significant portion of cancer cases reported nationally. Experts caution that early symptoms, such as seizures, headaches, and behavioral changes, could be critical indicators of these tumours, yet they often go unnoticed or misdiagnosed.
Dr. Anil Kumar, an oncologist at a leading cancer hospital, emphasized the importance of early detection. “Seizures can be an early warning sign of an underlying brain tumour. Anyone experiencing frequent unexplained seizures should undergo comprehensive neurological evaluation,” he advised. Delay in diagnosis can limit treatment options and reduce survival rates.
The ICMR report further stresses the variation in incidence rates among different regions, which may be influenced by genetic, environmental, and lifestyle factors. Urban areas show higher reported cases, possibly due to better diagnostic facilities and increased health awareness. However, rural populations may be underrepresented due to limited access to medical services.
Healthcare professionals advocate for public health initiatives targeting brain tumour awareness. Early symptoms should prompt timely medical consultation to facilitate prompt imaging studies such as MRI and CT scans, essential tools for accurate diagnosis. Treatment modalities vary from surgery, radiotherapy, to chemotherapy, depending on tumour type and stage.
Moreover, advances in neuro-oncology research continue to improve understanding of tumour biology, helping develop more effective, targeted therapies. Prevention remains challenging given the complex etiology, but reducing exposure to known risk factors, such as ionizing radiation and certain chemicals, is advisable.
In conclusion, the ICMR registry data signals a critical need for enhanced screening strategies and public education to improve outcomes for brain tumour patients. Timely recognition of seizure activity and other early symptoms can be lifesaving, emphasizing the role of both clinicians and communities in combating this serious health challenge.
